Results 181 to 190 of about 219,990 (308)

Putative Imprinting Control Regions with Aberrant Blood-Based DNA Methylation are Associated with Hepatocellular Carcinoma Risk. [PDF]

J Hepatocell Carcinoma
DiFrank AJ, Corliss BA, Park JJH, Rogers M, Skaar DA, Jima DD, Cowley M, Murphy SK, Liu A, Moylan CA, Hoyo C.   +10 more
europepmc   +1 more source

Methylation plus alpha-fetoprotein blood test for early detection of HCC in at-risk populations. [PDF]

Hepatol Commun
Parikh ND, Liu CC, DeMaio M, Yeh AH, Stackpole ML, Li S, Agopian VG, Li W, Zhou XJ, Ni X, Lok AS, Han SB.   +11 more
europepmc   +1 more source

Identification and credentialing of patient-derived xenograft models of invasive lobular carcinoma

Disease Models & Mechanisms
Jagmohan Hooda, Jennifer M. Atkinson, Osama Shiraz Shah, Megan Yates, Daniel D. Brown, Morgan DeBerry, Stefano Cairo, Paolo Schiavini, Hsiu-Wen Tsai, Marianna Zipeto, Rohit Bhargava, Steffi Oesterreich, Adrian V. Lee   +12 more
doaj   +1 more source

Carob pod aqueous extract potentiates cisplatin efficacy and reduces toxicity in experimental hepatocellular carcinoma via mitochondrial and inflammatory pathway modulation. [PDF]

Bioresour Bioprocess
Darwish WS, El Sayed Khadr A, Abd El Naby Kamel M, Addissouky TA, Ghareeb AZ, Eldaim MAA, Razzaq MK, El Tantawy El Sayed I, Abdel-Bary HM, Ghareeb DA.   +9 more
europepmc   +1 more source

Care-seeking among hepatocellular carcinoma patients in Uganda: health system navigation and its impact on diagnosis and survival in a prospective case-cohort study. [PDF]

BMJ Public Health
Nsibirwa SK, Aizire KJ, Okuku F, Ochola E, Mohareb AM, Ocama P, Kirk GD.   +6 more
europepmc   +1 more source

Hepatocellular Carcinoma-Related Mortality Trends Associated With Infective Versus Non-Infective Etiologies in ≥ 35 Years Age Group. [PDF]

Gastroenterology Res
Kakadiya J, Nasit Y, Vaghani M, Bhalala S, Fatima A, Rajapandian J, Varsadiya K, Ahmed Z.   +7 more
europepmc   +1 more source

Mortality Attributable to Hepatitis B and C in Italy, Romania, and Spain, 2022 Estimates. [PDF]

Liver Int
Korotych O, Thygesen HH, Mårdh O, Reyes-Urueña J, Marrone G, Rockstroh J, Jakobsen ML, de Martel C, Kondili LA, Quaranta MG, Mattioli B, Rosato S, Rendina M, De Feudis A, Cossiga V, Albano S, Morisco F, Viganò M, Loglio A, Fagiuoli S, Calvaruso V, Celsa C, Longobardi F, Coppola R, Russo FP, Battistella S, Coppola N, Sagnelli C, Coco B, Brunetto MR, Popovici O, Janță D, Calomfirescu C, Gheorghe LS, Ghioca M, Ester C, Chitul M, Cerban R, Trifan A, Huiban L, Muzica C, Popescu A, Sirli R, Nica C, Popa A, Ferret MB, Vargas-Accarino E, Díaz A, Méndez CF, Morano L, Alonso S, Ahumada A, Cañizares RB, Raben D, Duffell E.   +54 more
europepmc   +1 more source

Tumor-Associated Macrophages in Hepatocellular Carcinoma: From Ontogeny and Heterogeneity to Immune Evasion and Therapeutic Targeting. [PDF]

J Hepatocell Carcinoma
Su Y, Liang Y, Zhong D, Chen Y, Ma SS, Huang X.   +5 more
europepmc   +1 more source

Skrining HCC-a

53. Simpozijum "Stremljenja i novine u medicini" - zbornik radova
Rano otkrivanje hepatocelularnog karcinoma od presudne je važnosti za uspešno lečenje. Skrining programi se baziraju na praćenju rizičnih grupa, pre svega bolesnika sa cirozom i hroničnim hepatitisom B ili C. Ultrazvuk abdomena svakih šest meseci predstavlja standardnu metodu, dok određivanje alfa-fetoproteina može imati dodatnu vrednost.
openaire   +2 more sources

Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma” [PDF]

Clinical and Molecular Hepatology
Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su   +2 more
doaj   +1 more source